Terry D Copeland

Title: The Innovations of Terry D Copeland

Introduction

Terry D Copeland is a notable inventor based in Frederick, MD (US). She has made significant contributions to the field of antiviral treatments, holding a total of 4 patents. Her work focuses on developing compounds and methods to combat viral infections, particularly those related to human immunodeficiency virus (HIV).

Latest Patents

Among her latest patents, one includes the invention of 2,3-epoxy alcohols, acids, and derivatives as anti-retroviral agents. This invention relates to compounds, compositions, and methods for treating viral infections. The compounds have a general formula where R is selected from various functional groups, indicating a diverse range of potential applications. Another significant patent involves the identification and sequencing of the HIV protease, which is essential for the natural synthesis of HIV. This work has led to the development of synthetic HIV-1 and HIV-2 proteases with specific stereospecific conformation and activity.

Career Highlights

Throughout her career, Terry has worked with prominent organizations, including the United States of America as represented by the Department of Health and the Secretary of Health. Her innovative research has contributed to advancements in the treatment of viral infections, showcasing her expertise in the field.

Collaborations

Terry has collaborated with notable individuals such as Stephen Oroszlan and Jeffrey J Blumenstein. These partnerships have further enhanced her research and development efforts in antiviral therapies.

Conclusion

Terry D Copeland's contributions to antiviral research and her innovative patents highlight her role as a significant inventor in the field. Her work continues to impact the development of treatments for viral infections, showcasing the importance of innovation in healthcare.